FDA restricts use of cough and cold medicines with codeine or hydrocodone for kids

January 11, 2018
Area(s) of Interest: Drug Prescribing/Dispensing Patient Care 

The U.S. Food and Drug Administration (FDA) said today that cough and cold medicines containing codeine and hydrocodone should not be prescribed to children and adolescents because of serious safety risks posed by the opioid ingredients. The FDA also announced that such products will now be required to carry ""boxed warnings"" – the FDA’s strongest warning – that highlight the risks misuse, abuse, addiction, overdose, death, and slowed or difficult breathing.

According to the FDA, it is taking this action after an extensive review that determined the risks associated with these medicines outweigh their benefits in patients younger than 18.

Click here for more information.


Was this article helpful?    

COVID-19 Resources

Resources for physicians and health care providers on the latest news, research and developments.

Stay Informed

Opt in to receive updates on the latest health care news, legislation, and more.

Latest News

Load More